Athersys (ATHX) Misses Q1 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. AVGO
3. CDNS
4. ANT
5. META
6. BA
7. SPY
8. INTC
9. JBLU
10. HOOD

Go back to Athersys (ATHX) Misses Q1 EPS by 2c

Athersys Reports First Quarter 2020 Results

May 7, 2020 4:05 PM EDT

Management to host conference call at 4:30 pm EDT today

CLEVELAND--(BUSINESS WIRE)-- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended March 31, 2020.

Highlights of the first quarter of 2020 and recent events include:

Received authorization from the U.S. Food and Drug Administration (FDA) to initiate a Phase 2/3 COVID-19 induced acute respiratory distress syndrome (ARDS) clinical trial; completed site initiation and began enrolling patients in this trial referred to as the MACOVIA study; Received FDA authorization to... More